/Lists

Biotech Investors & VC Firms in Japan

156 firms in this list, with a median first check of $400K. 33 of them lead rounds. Generated from verified public data and updated continuously.

Japan Investment
TokyoPre-Seed–Late Stage
1 person
T Capital Partners Co. Ltd.
TokyoGrowth–Late Stage$4B – $14B
4 people
Medical Incubator Japan K.K.
TokyoSeries A–Series B
11 people
Vision Incubate
KanazawaPre-Seed–Growth
11 people
MITSUBISHI CHEMICAL
Seed–Growth
14 people
Mitsubishi UFJ Capital
TokyoPre-Seed–Growth
5 people
DCI Partners Co. Ltd.
TokyoSeed–Growth
13 people
WERU Investment Co. Ltd.
TokyoSeed–Series A
11 people
Oita Venture Capital
OitaPre-Seed–Growth
1 person
Hiroshima Innovation Network
HiroshimaGrowth
13 people
IDATEN Ventures
TokyoSeed–Series A
2 people
BioFrontier Partners, Inc.
TokyoSeries A–Late Stage$500K – $3M
15 people
Mitsui Sumitomo Insurance Capital
TokyoPre-Seed–Growth
3 people
Tokyo University of Science Innovation Capital
TokyoPre-Seed–Growth
4 people
AIS CAPITAL
TokyoSeries A
9 people
Iwagin Business Creation Capital
MoriokaSeed–Growth
9 people
Strategic Investment Partners Inc.
TokyoSeed–Growth
8 people
Shinsei Capital Partners
TokyoPre-Seed–Late Stage
6 people
Mizuho Capital
TokyoPre-Seed–Growth
1 person
GOLDWIN VENTURE PARTNERS
TokyoSeed–Growth
3 people
Ono Digital health Investment, GK.
OsakaPre-Seed–Late Stage
4 people
Global Startup Acceleration Program (JETRO GSAP)
TokyoPre-Seed–Late Stage
Japan Asia Investment
TokyoPre-Seed–Late Stage$1M – $10M
1 person
Red Capital
TokyoSeed
3 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.